PMID: 9661033Jul 14, 1998Paper

Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus

Antimicrobial Agents and Chemotherapy
C Tremblay, C Gaudreau

Abstract

The susceptibilities of 59 Campylobacter fetus subsp. fetus isolates to eight antibiotics were studied by the agar dilution, E-test, and disk diffusion methods. None of the isolates were beta-lactamase producers. All were susceptible to ampicillin, gentamicin, imipenem, and meropenem as determined by the three methods, with MICs at which 90% of the isolates are inhibited (MIC90s) (determined by agar dilution) of 2, 1, < or = 0.06, and 0.12 microgram/ml, respectively. Twenty-seven percent of the isolates were resistant to tetracycline, with complete agreement between the agar dilution and disk diffusion results. The MIC90s determined by agar dilution were 2 micrograms/ml for erythromycin, 1 microgram/ml for ciprofloxacin, and 8 micrograms/ml for cefotaxime.

References

Mar 1, 1978·Antimicrobial Agents and Chemotherapy·A W ChowD Bednorz
Jul 1, 1992·Diagnostic Microbiology and Infectious Disease·C N Baker
May 1, 1991·Antimicrobial Agents and Chemotherapy·N LachanceL A Larivière
Aug 1, 1989·The Journal of Antimicrobial Chemotherapy·H GoossensJ P Butzler
Sep 1, 1989·The Pediatric Infectious Disease Journal·T MorookaH Shigeoka
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·D E Taylor, P Courvalin
Apr 1, 1988·Clinical Microbiology Reviews·J L Penner
Mar 1, 1985·Antimicrobial Agents and Chemotherapy·R M FliegelmanR L Kaplan
Jan 1, 1974·Antimicrobial Agents and Chemotherapy·J P ButzlerT Lafontaine
Mar 1, 1981·The Journal of Infectious Diseases·D R SpelhaugJ A Washington
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·D E TaylorB J Allan
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·R SánchezE Bouza
Jun 1, 1993·Epidemiology and Infection·M B SkirrowJ Benjamin
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A MonteroI H Ballón

❮ Previous
Next ❯

Citations

Jun 6, 2007·Acta Clinica Belgica·T GoegebuerI Surmont
Aug 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jérôme PacanowskiUNKNOWN CAMPYL Study Group
Feb 1, 2008·Pacing and Clinical Electrophysiology : PACE·Walid AhmarNeil Strathmore
Dec 3, 2016·Intractable & Rare Diseases Research·Abhinav Agrawal, Rutuja R Sikachi
Mar 28, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anne-Elisabeth HengPatrice Deteix
Nov 14, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L GazaigneP Lesprit
Jun 21, 2016·Infectious Diseases·Khetam HusseinImad Kassis
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G AnsteadT Patterson
Feb 3, 2007·FEMS Immunology and Medical Microbiology·David A Alfredson, Victoria Korolik
Aug 29, 2021·Journal of Infection and Public Health·Bassem AwadaSouha S Kanj
Aug 12, 2008·Journal of Vascular Surgery·Frédéric CochennecJean-Pierre Becquemin
Oct 27, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S S KanjL B Reller

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.